Zomedica Pharmaceuticals Corp Stock Technical Analysis
| ZOM Stock | USD 0.12 0 2.50% |
As of the 13th of December 2024, Zomedica Pharmaceuticals maintains the Market Risk Adjusted Performance of (0.09), mean deviation of 1.76, and Standard Deviation of 3.93. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zomedica Pharmaceuticals Corp, as well as the relationship between them. Please check out Zomedica Pharmaceuticals market risk adjusted performance and treynor ratio to decide if Zomedica Pharmaceuticals is priced fairly, providing market reflects its latest price of 0.123 per share. As Zomedica Pharmaceuticals appears to be a penny stock we also urge to confirm its jensen alpha numbers.
Zomedica Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Zomedica, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ZomedicaZomedica |
Zomedica Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 6.0 | Strong Buy | 1 | Odds |
Most Zomedica analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Zomedica stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Zomedica Pharmaceuticals, talking to its executives and customers, or listening to Zomedica conference calls.
Zomedica Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Zomedica Pharmaceuticals Technical Analysis
The output start index for this execution was fifty-two with a total number of output elements of nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Zomedica Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Zomedica Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Zomedica Pharmaceuticals Corp. You can use it to identify possible trend reversals for Zomedica Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Zomedica Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Zomedica Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Zomedica Pharmaceuticals Corp applied against its price change over selected period. The best fit line has a slop of 0 , which may imply that the returns on investment in Zomedica Pharmaceuticals Corp will continue to fail. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Zomedica Pharmaceuticals price change compared to its average price change.About Zomedica Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Zomedica Pharmaceuticals Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Zomedica Pharmaceuticals Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Zomedica Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Zomedica Pharmaceuticals. By analyzing Zomedica Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Zomedica Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Zomedica Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 35.94 | 31.85 | 49.64 | PTB Ratio | 0.6 | 0.82 | 0.78 |
Zomedica Pharmaceuticals December 13, 2024 Technical Indicators
Most technical analysis of Zomedica help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Zomedica from various momentum indicators to cycle indicators. When you analyze Zomedica charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.0005) | |||
| Market Risk Adjusted Performance | (0.09) | |||
| Mean Deviation | 1.76 | |||
| Coefficient Of Variation | (8,371) | |||
| Standard Deviation | 3.93 | |||
| Variance | 15.41 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.1) | |||
| Maximum Drawdown | 24.36 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 7.69 | |||
| Skewness | 1.04 | |||
| Kurtosis | 5.29 |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zomedica Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.06) | Revenue Per Share 0.027 | Quarterly Revenue Growth 0.018 | Return On Assets (0.09) | Return On Equity (0.24) |
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.